ASH 2022 Conference Coverage
J

ASH 2022 Phase III SUNMO Trial: Evaluating the Efficacy & Safety of Mosunetuzumab + Polatuzumab Vedotin vs. Rituximab + Gemcitabine & Oxaliplatin in R/R Aggressive B-Cell NHL

By ASH 2022 Conference Coverage FEATURING Jason Westin
By ASH 2022 Conference Coverage FEATURING Jason Westin
298 views
December 19, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Related Videos

27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

665 views
25:22

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

103 views
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

310 views
17:07

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Mana…

2024 ASCO® Annual Meeting Insights Hub

M. Minnema

284 views
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

924 views
16:27

Therapeutic Advances in T-Cell Lymphoma in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Barta

296 views
17:21

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…

Daniel Addison

387 views
13:58

EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…

Insights from 2024 EHA Annual Meeting

M. Salamoon

124 views
22:38

Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…

Indy Hematology Review

T. Phillips

152 views
05:38

Epcoritamab in NHL - Incidence and Management of CRS

GRACE

T. Phillips

172 views
20:25

What Is the Best Timing for Bispecific Antibodies and CAR-T Therapy …

SOHO Brazil 2024

A. Zelenetz

57 views
26:58

Update on Cellular Therapy in Lymphoma

Total Health

B. Randolph

114 views
40:51

New

2024 Updates in the Management of DLBCL, FL, and HL

UNC Lineberger Comprehensive Cancer Center

A. Beaven

23 views
22:06

Current Overview of Biscpecific Antibodies in Hematologic Malignanci…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

B. Uncu Ulu

50 views
15:14

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

873 views
06:51

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

433 views
08:05

ASCO® 2024 Insights: "TRANSFORM Study - 3-Year Follow-Up Comparing L…

2024 ASCO® Annual Meeting Insights Hub

M. Kamdar

76 views
07:01

FDA Approval of Liso-Cel in R/R FL: What You Need to Know

Loretta Nastoupil

70 views
12:05

The Evolving Role for Bispecific Antibodies in B-Cell Lymphoma

UChicago Medicine

T. Mccabe

43 views
17:37

Experts Discuss Choosing BTKis in CLL, Sequencing Therapy in NHL, an…

Massachusetts General Hospital Cancer Center

J. Soumerai, J. Erika Haydu

72 views
AUTOPLAY